"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Descriptor ID |
D016019
|
MeSH Number(s) |
E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
|
Concept/Terms |
Survival Analysis- Survival Analysis
- Analysis, Survival
- Analyses, Survival
- Survival Analyses
|
Below are MeSH descriptors whose meaning is more general than "Survival Analysis".
Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".
This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 11 | 11 |
1995 | 2 | 13 | 15 |
1996 | 1 | 15 | 16 |
1997 | 1 | 13 | 14 |
1998 | 0 | 17 | 17 |
1999 | 0 | 26 | 26 |
2000 | 1 | 28 | 29 |
2001 | 0 | 31 | 31 |
2002 | 1 | 32 | 33 |
2003 | 0 | 45 | 45 |
2004 | 0 | 52 | 52 |
2005 | 1 | 46 | 47 |
2006 | 0 | 57 | 57 |
2007 | 0 | 47 | 47 |
2008 | 2 | 48 | 50 |
2009 | 0 | 47 | 47 |
2010 | 1 | 43 | 44 |
2011 | 2 | 42 | 44 |
2012 | 0 | 42 | 42 |
2013 | 0 | 29 | 29 |
2014 | 0 | 42 | 42 |
2015 | 0 | 35 | 35 |
2016 | 1 | 42 | 43 |
2017 | 3 | 58 | 61 |
2018 | 3 | 47 | 50 |
2019 | 0 | 44 | 44 |
2020 | 0 | 35 | 35 |
2021 | 1 | 27 | 28 |
2022 | 1 | 4 | 5 |
2023 | 0 | 3 | 3 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Analysis" by people in Profiles.
-
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. Am J Respir Crit Care Med. 2024 Sep 01; 210(5):639-647.
-
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25; 391(4):320-333.
-
Palliative Care Use Trends, Racial/Ethnic Disparities, and Overall Survival Differences Among Patients With Metastatic Breast Cancer. J Palliat Med. 2024 Jun; 27(6):763-775.
-
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study. Lancet Oncol. 2024 Jan; 25(1):29-45.
-
A Nationwide Analysis of Head and Neck Fibromatoses. Laryngoscope. 2024 May; 134(5):2228-2235.
-
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma. N Engl J Med. 2023 Jul 13; 389(2):148-157.
-
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022 11 22; 6(22):5898-5907.
-
Computational Analysis of High-Dimensional DNA Methylation Data for Cancer Prognosis. J Comput Biol. 2022 08; 29(8):769-781.
-
Multicenter Development and Validation of a Model for Predicting Retention in Care Among People with HIV. AIDS Behav. 2022 Oct; 26(10):3279-3288.
-
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun. 2022 01 20; 13(1):405.